However, the prognosis of over 90% of infant ALL and 35–50% of childhood acute myeloid leukemia remains poor because of harboring the mixed-lineage leukemia gene (MLL) fusion [4–8]. This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.